Transgenic Group Inc. (TYO:2342)
178.00
-4.00 (-2.20%)
Nov 18, 2026, 11:09 AM JST
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 2.96 billion as of November 17, 2026. It is the 36,733rd most valuable company in the world and the 3,391st biggest in Japan. Its market cap has decreased by 9.64% in one year.
Market Cap
2.96B
Enterprise Value
3.61B
Revenue
14.02B
Global Rank
Country Rank
#3,391 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 2.96B, a decrease of -69.68%. That is a compound annual growth rate of -4.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 2.96B | -41.64% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 4.84B |
| Kringle Pharma | 4.43B |
| SUSMED,Inc. | 4.27B |
| Noile-Immune Biotech | 3.52B |
| Chordia Therapeutics | 3.40B |
| Kohjin Bio | 3.34B |
| Modalis Therapeutics | 3.30B |
| PRISM BioLab Co.,LTD | 3.22B |